Inhibitory effect of protease inhibitor on endothelial cell activation

Journal of Surgical Research

Volumn 80, Issue 2, 1998, Pages 182-187

  Aosasa, Suefumi ^a   Ono, Satoshi ^a   Seki, Shuhji ^a   Takayama, Eiji ^a   Tadakuma, Takushi ^a   Hiraide, Hoshio ^a   Mochizuki, Hidetaka ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Gabexate mesilate; Inter cellular adhesion molecule 1 (ICAM 1); Plasminogen activator inhibitor type 1 (PAI 1); TNF ; Ulinastatin

Indexed keywords

GABEXATE MESILATE; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN;

ARTICLE; CELL ACTIVATION; DRUG EFFECT; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032418417     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5474     Document Type: Article

References (32)

1. Kornelisse R. F., Hazelzet J. A., Savelkoul H. F., Hop W. C., Suur M. H., Borsboom A. N., Risseeuw-Appel I. M., van der Voort E., de Groot R. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J. Infect. Dis. 173:1996;1148.
2. Salgado A., Boveda J. L., Monasterio J., Segura R. M., Mourelle M., Gomez-Jimenez J., Peracaula R. Inflammatory mediators and their influence on haemostasis. Haemostasis. 24:1994;132.
3. Carlos T. M., Harlan J. M. Leukocyte-endothelial adhesion molecules. Blood. 84:1994;2068.
4. Menger M. D., Vollmar B. Adhesion molecules as determinants of disease: From molecular biology to surgical research. Br. J. Surg. 83:1996;588.
5. Lee C. H., Reid Y. A., Jong J. S., Kang Y. H. Lipopolysaccharide-induced differential cell surface expression of intercellular adhesion molecule-1 in cultured human umbilical cord vein endothelial cells. Shock. 3:1995;96.
6. Taenaka N., Shimada Y., Hirata T., Nishijima M. K., Takezawa J., Yoshiya I., Kambayashi J. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis. Crit. Care Med. 11:1983;735.
7. Tani T., Aoki H., Yoshioka T., Lin K. J., Kodama M. Treatment of septic shock with a protease inhibitor in a canine model: A prospective, randomized, controlled trial. Crit. Care Med. 21:1993;925.
8. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52:1973;2745.
9. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294.
10. Fajardo L. F. The complexity of endothelial cells. Am. J. Clin. Pathol. 92:1989;241.
11. Yamashita M., Yamashita M. Tumor necrosis factor alpha is involved in the induction of plasminogen activator inhibitor-1 by endotoxin. Thromb. Res. 87:1997;165.
12. Zoellner H., Wojta J., Gallicchio M., McGrath K., Hamilton J. A. Cytokine regulation of the synthesis of plasminogen activator inhibitor-2 by human vascular endothelial cells: Comparison with plasminogen activator inhibitor-1 synthesis. Thromb. Haemost. 69:1993;135.
13. Gando S., Kameue T., Nanzaki S., Nakanishi Y. Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome. Thromb. Res. 80:1995;519.
14. Massignon D., Lepape A., Bienvenu J., Barbier Y., Boileau C., Coeur P. Coagulation/fibrinolysis balance in septic shock related to cytokines and clinical state. Haemostasis. 24:1994;36.
15. Mackman N. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers. J. Biol. Chem. 269:1994;26363.
16. Gregory S. A., Morrissey J. H., Edgington T. S. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol. Cell. Biol. 9:1989;2752.
17. Loskutoff D. J., Sawdey M., Mimuro J. Type 1 plasminogen activator inhibitor. Prog. Hemost. Thromb. 9:1989;87.
18. Niedbala M. J., Stein-Picarella M. Tumor necrosis factor regulation of endothelial cell extracellular proteolysis: The role of urokinase plasminogen activator. Biol. Chem. Hoppe Seyler. 373:1992;555.
19. Tamura Y., Hirado M., Okamura K., Minato Y., Fujii S. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase. Biochim. Biophys. Acta. 484:1977;417.
20. Takemoto Y., Tanaka S., Tanabe J., Nakamura Y., Kohama A., Shibata S. Studies on the effects of primary therapy for DIC following circulatory arrest. Am. J. Hematol. 21:1986;377.
21. Tamaki S., Wada H., Hiyoyama K., Shimura M., Minamikawa K., Wakita Y., Nakase T., Ohiwa M., Kaneko T., Iwasaki E. Treatment of disseminated intravascular coagulation with gabexate mesilate. Clin. Ther. 15:1993;1076.
22. Chen H. M., Hwang T. L., Chen M. F. The effect of gabexate mesilate on pancreatic and hepatic microcirculation in acute experimental pancreatitis in rats. J. Surg. Res. 66:1996;147.
23. Ohnishi H., Kosuzume H., Ashida Y., Kato K., Honjo I. Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis. Dig. Dis. 29:1984;26.
24. Endo S., Inada K., Taki K., Hoshi S., Yoshida M. Inhibitory effects of ulinastatin on the production of cytokines: Implications for the prevention of septicemic shock. Clin. Ther. 12:1990;323.
25. Aibiki M., Cook J. A. Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human monocytes. Crit. Care Med. 25:1997;430.
26. McGeehan G. M., Becherer J. D., Bast R. C. Jr., Boyer C. M., Champion B., Connolly K. M., Conway J. G., Furdon P., Karp S., Kidao S., McElroy A. B., Nichols J., Pryzwansky K. M., Schoenen F., Sekut L., Truesdale A., Verghese M., Warner J., Ways J. P. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature. 370:1994;558.
27. Gearing A. J., Beckett P., Christodoulou M., Churchill M., Clements J., Davidson A. H., Drummond A. H., Galloway W. A., Gilbert R., Gordon J. L., Leber T. M., Mangan M., Miller K., Nayee P., Owen K., Patel S., Thomas W., Wells G., Wood L. M., Woolley K. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature. 370:1994;555.
28. Lo C. J., Fu M., Kim B. Macrophage TNF mRNA expression is modulated by protease inhibitors. J. Surg. Res. 69:1997;408.
29. Chen C. C., Rosenbloom C. L., Anderson D. C., Manning A. M. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J. Immunol. 155:1995;3538.
30. Remick D. G. Applied molecular biology of sepsis. J. Crit. Care. 10:1995;198.
31. Descheemaeker K. A., Wyns S., Nelles L., Auwerx J., Ny T., Collen D. Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response. J. Biol. Chem. 267:1992;15086.
32. Fearns C., Loskutoff D. J. Induction of plasminogen activator inhibitor 1 gene expression in murine liver by lipopolysaccharide: Cellular localization and role of endogenous tumor necrosis factor-alpha. Am. J. Pathol. 150:1997;579.